We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Independent Market Research Ranks Sysmex in Hematology Instruments

By LabMedica International staff writers
Posted on 17 Mar 2009
In IMV's 2008 ServiceTrak annual report Sysmex America (Mundelein, IL, USA) was ranked best in hematology instrument reliability and industry for the ninth consecutive year. More...
Sysmex also ranked first in 21 of the 30 survey factors, including all five Original Equipment Manufacturer (OEM) service performance factors and all five manufacturer and instrument performance factors. The IMV ServiceTrak survey respondents include clinical laboratory department supervisors, laboratory managers, and technologists chosen at random from hospitals of varying sizes from across the country.

For customer satisfaction, Sysmex hematology instruments also ranked first in MD Buyline's January 2009 User Satisfaction Ratings. MD Buyline survey respondents include technologists and clinicians from hospitals and clinical reference laboratories located throughout the United States. MD Buyline is a comprehensive database of information on healthcare products.

"Regardless of the healthcare industry's economic concerns, we know our customers must provide high quality care for their patients. As a healthcare partner to many of the nation's healthcare facilities, we are honored that our hematology instruments have met their needs in reliability and performance expectations," said John Kershaw, president, Sysmex America, Inc.

Instrument reliability also impacts clinical laboratory performance metrics such as results turnaround time and repeat rate. Switching to backup analyzers could create issues with shifting normal ranges and consistency of results used in patient trending analysis. "Therefore, clinical laboratories will want to assess their instrument capability relative to their effect on service lines, care pathways, medical errors, and patient flow," added Mr. Kershaw.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), distributes and supports automated in vitro diagnostic hematology, coagulation, and urinalysis analyzers, reagents, and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The company focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.

Related Links:

Sysmex America



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.